{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:06:23Z","timestamp":1779123983146,"version":"3.51.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Alcoholic hepatitis is a severe inflammatory liver disease. In recent years, the incidence of AH has been on the rise, leading to an increasingly severe disease burden. Currently, there is a lack of specific biomarkers for the diagnosis and prognosis of AH in clinical practice. Therefore, the main objective of this study is to identify biomarkers closely associated with the progression of AH, to address the shortcomings in pathological diagnosis, and to identify potential therapeutic targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Bioinformatics and machine learning methods were used to comparatively study the differentially expressed genes (DEGs) between AH patients and healthy individuals by analyzing four mRNA microarray data sets obtained from the GEO database. Subsequently, the role of potential biomarkers in AH and their mechanism of action were further confirmed by AH patients and <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Using differential analysis and WGCNA of the data set, a total of 167 key genes that may be related to AH were obtained. Among 167 genes, the LASSO logistic regression algorithm identified four potential biomarkers (KCNJ10, RPL21P23, ADRB2, and AC025279.1). Notably, ADRB2 showed biomarker potential in GSE28619, GSE94397, and E-MTAB-2664 datasets, and clinical liver samples. Furthermore, AH patients and <jats:italic>in vivo<\/jats:italic> experiments demonstrated ADRB2 inhibition and suppression of SIRT1\/PPAR\u03b1\/PGC-1\u03b1 signaling pathways, accompanied by elevated inflammatory factors and lipid deposition. <jats:italic>In vitro<\/jats:italic> experiments showed that ADRB2 overexpression mitigated the inhibition of the SIRT1\/PPAR\u03b1\/PGC-1\u03b1 signaling pathway, reversing the decrease in mitochondrial membrane potential, cell apoptosis, oxidative stress, and lipid deposition induced by alcohol exposure. Besides, the results also showed that ADRB2 expression in AH was negatively correlated with the levels of inflammatory factors (e.g., CCL2, CXCL8, and CXCL10).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study points to ADRB2 as a promising biomarker with potential diagnostic and prognostic value in clinical cohort data. In addition, in AH patients, <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> experiments confirmed the key role of ADRB2 in the progression of AH. These findings suggest that ADRB2 may alleviate AH by activating the SIRT1\/PPAR\u03b1\/PGC-1\u03b1 pathway. This finding provides a new perspective for the diagnosis and treatment of AH.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1423031","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:42:50Z","timestamp":1732164170000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1\/PGC-1\u03b1\/PPAR\u03b1 pathway: integration of WGCNA, machine learning and experimental validation"],"prefix":"10.3389","volume":"15","author":[{"given":"Li","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haozhe","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanglu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/hep.30249","article-title":"Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice","volume":"69","author":"Ambade","year":"2019","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/gutjnl-2019-319720","article-title":"Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting","volume":"69","author":"Avila","year":"2020","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/s0168-8278(20)30852-7","article-title":"Non-invasive criteria for diagnosis of alcoholic hepatitis: use in clinical practice and correlation with prognosis","volume":"73","author":"Avitabile","year":"2020","journal-title":"J. Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"Bataller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat. Protoc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.7150\/thno.44960","article-title":"Kupffer cells promote T-cell hepatitis by producing CXCL10 and limiting liver sinusoidal endothelial cell permeability","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1093\/eurheartj\/ehae362","article-title":"Alcoholic cardiomyopathy: an update","volume":"45","author":"Dominguez","year":"2024","journal-title":"Eur. Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"109400","DOI":"10.1016\/j.intimp.2022.109400","article-title":"A novel reactive aldehyde species inhibitor prevents the deleterious effects of ethanol in an animal model of alcoholic liver disease","volume":"113","author":"Duryee","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cels.2021.04.004","article-title":"Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific manner","volume":"12","author":"Esmaili","year":"2021","journal-title":"Cell Syst."},{"key":"B11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","article-title":"Targeting the CCL2-CCR2 axis for atheroprotection","volume":"43","author":"Georgakis","year":"2022","journal-title":"Eur. Heart J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12864-016-3435-2","article-title":"Meta-analysis reveals conserved cell cycle transcriptional network across multiple human cell types","volume":"18","author":"Giotti","year":"2017","journal-title":"BMC Genomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/HEP.0000000000000303","article-title":"The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent","volume":"78","author":"Goikoetxea-Usandizaga","year":"2023","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2022.0017","article-title":"Subclinical versus advanced forms of alcohol-related liver disease: need for early detection","volume":"29","author":"Gomez-Medina","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","article-title":"A guide to machine learning for biologists","volume":"23","author":"Greener","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.jhepr.2022.100466","article-title":"Epigenetics of alcohol-related liver diseases","volume":"4","author":"Habash","year":"2022","journal-title":"JHEP Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1681\/ASN.2020121723","article-title":"Activation of sympathetic signaling in macrophages blocks systemic inflammation and protects against renal ischemia-reperfusion injury","volume":"32","author":"Hasegawa","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1146693","DOI":"10.3389\/fimmu.2023.1146693","article-title":"Identification of biomarkers co-associated with M1 macrophages, ferroptosis and cuproptosis in alcoholic hepatitis by bioinformatics and experimental verification","volume":"14","author":"Hou","year":"2023","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2301645","DOI":"10.1002\/advs.202301645","article-title":"Adipose METTL14-elicited N6 -methyladenosine promotes obesity, insulin resistance, and NAFLD through suppressing \u03b2 adrenergic signaling and lipolysis","volume":"10","author":"Kang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13046-020-01782-w","article-title":"Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPAR\u03b1 to activate the NF-\u03baB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance","volume":"40","author":"Kong","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"100615","DOI":"10.1016\/j.jhepr.2022.100615","article-title":"Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity","volume":"5","author":"Larsen","year":"2023","journal-title":"JHEP Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41598-017-18705-z","article-title":"Application of weighted gene Co-expression network analysis for data from paired design","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"12359","DOI":"10.1074\/jbc.RA119.007409","article-title":"Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria","volume":"294","author":"Liang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/biom12081151","article-title":"Klotho levels and their relationship with inflammation and survival among alcoholic patients","volume":"12","author":"Martin-Gonzalez","year":"2022","journal-title":"Biomolecules"},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.14309\/ajg.0000000000001042","article-title":"Keratin-18: diagnostic, prognostic, and theragnostic for alcohol-associated hepatitis","volume":"116","author":"Mcclain","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"Morgan","year":"2010","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"124581","DOI":"10.1016\/j.ijbiomac.2023.124581","article-title":"A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: call for further research","volume":"242","author":"Nandave","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"153919","DOI":"10.1016\/j.phymed.2021.153919","article-title":"Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPAR\u03b1\/PGC-1\u03b1-mediated mitochondrial oxidative metabolism","volume":"98","author":"Ni","year":"2022","journal-title":"Phytomedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.3390\/ijms22136921","article-title":"Intestinal permeability is a mechanical rheostat in the pathogenesis of liver cirrhosis","volume":"22","author":"Nishimura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","article-title":"Noninvasive proteomic biomarkers for alcohol-related liver disease","volume":"28","author":"Niu","year":"2022","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"101220","DOI":"10.1016\/j.molmet.2021.101220","article-title":"Macrophage beta2-adrenergic receptor is dispensable for the adipose tissue inflammation and function","volume":"48","author":"Petkevicius","year":"2021","journal-title":"Mol. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cld.2021.03.010","article-title":"Current and future biomarkers in alcoholic hepatitis","volume":"25","author":"Rutledge","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2018.10.026","article-title":"Current trials and novel therapeutic targets for alcoholic hepatitis","volume":"70","author":"Singal","year":"2019","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jhep.2022.03.025","article-title":"Therapeutic advances in alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"J. Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3350\/cmh.2020.0203","article-title":"Alcohol and hepatocarcinogenesis","volume":"26","author":"Taniai","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41419-022-04998-0","article-title":"\u03b22-adrenergic receptor promotes liver regeneration partially through crosstalk with c-met","volume":"13","author":"Tao","year":"2022","journal-title":"Cell Death Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbrc.2019.02.037","article-title":"Genetic deletion of \u03b22 adrenergic receptors exacerbates hepatocellular lipid accumulation in high-fat diet mice","volume":"511","author":"Tao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41366-023-01270-z","article-title":"Physiological and molecular mechanisms of cold-induced improvements in glucose homeostasis in humans beyond brown adipose tissue","volume":"47","author":"Van Beek","year":"2023","journal-title":"Int. J. Obes. (Lond)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"E619","DOI":"10.1152\/ajpendo.00324.2020","article-title":"Prolonged \u03b22-adrenergic agonist treatment improves glucose homeostasis in diet-induced obese UCP1-\/- mice","volume":"320","author":"Van Beek","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"S116-S129","DOI":"10.1080\/10408398.2018.1544542","article-title":"n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: a critical review","volume":"59","author":"Wang","year":"","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e3000563","DOI":"10.1371\/journal.pbio.3000563","article-title":"Mediator MED23 regulates inflammatory responses and liver fibrosis","volume":"17","author":"Wang","year":"","journal-title":"PLoS Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/gutjnl-2015-310344","article-title":"Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors","volume":"66","author":"Wieser","year":"2017","journal-title":"Gut"},{"key":"B47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cac2.12247","article-title":"Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1","volume":"42","author":"Wu","year":"","journal-title":"Cancer Commun. (Lond)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","article-title":"The sirtuin family in health and disease","volume":"7","author":"Wu","year":"","journal-title":"Signal Transduct. Target Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1039\/c6fo01166g","article-title":"The biphasic dose effect of lychee (Litchi chinensis Sonn.) pulp phenolic extract on alcoholic liver disease in mice","volume":"8","author":"Xiao","year":"2017","journal-title":"Food Funct."},{"key":"B50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.envint.2019.03.057","article-title":"PM(2.5)-induced ADRB2 hypermethylation contributed to cardiac dysfunction through cardiomyocytes apoptosis via PI3K\/Akt pathway","volume":"127","author":"Yang","year":"2019","journal-title":"Environ. Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1021\/acs.jproteome.3c00093","article-title":"Metabolomics reveals gut microbiota contribute to PPAR\u03b1 deficiency-induced alcoholic liver injury","volume":"22","author":"Zhang","year":"2023","journal-title":"J. Proteome Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.freeradbiomed.2020.08.006","article-title":"Cyanidin-3-O-\u03b2-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1\/NF-\u03baB signaling pathway","volume":"160","author":"Zhou","year":"2020","journal-title":"Free Radic. Biol. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1423031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:42:54Z","timestamp":1732164174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1423031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":49,"alternative-id":["10.3389\/fphar.2024.1423031"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1423031","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"article-number":"1423031"}}